Exercise-Based Cardiac Rehabilitation Aids Atrial Fibrillation
THURSDAY, July 31, 2025 -- Exercise-based cardiac rehabilitation (ExCR) shows clinical benefits in patients with atrial fibrillation (AF), according to a review published online July 29 in the British Journal of Sports Medicine.
Benjamin J.R. Buckley, Ph.D., from Liverpool John Moores University in the United Kingdom, and colleagues conducted a systematic literature review to assess the impact of ExCR for patients with AF.
Based on 20 randomized controlled trials (2,039 participants), the researchers found that over a mean follow-up of 11 months, ExCR did not impact all-cause mortality (8.3 versus 6.0 percent; relative risk [RR], 1.06, 95 percent confidence interval [CI], 0.76 to 1.48) or serious adverse events (2.9 versus 4.1 percent; RR 1.30, 95 percent CI, 0.66 to 2.56). ExCR did reduce AF symptom severity (mean difference [MD] −1.61), AF burden (MD, −1.61), episode frequency (MD, −0.57), episode duration (MD, −0.58), AF recurrence (RR, 0.68; 95 percent CI, 0.53 to 0.89), and improved exercise capacity (maximal oxygen consumption MD, 3.18 mL/kg/min). For quality of life, there was benefit for the mental component but not the physical component.
"AF management guidelines should reflect this updated evidence base by recommending ExCR alongside drug and ablation therapies for patients with AF," the authors write.
Several authors disclosed ties to the pharmaceutical and technology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Cancer Survival Lower in Rural Areas
WEDNESDAY, Oct. 1, 2025 -- Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White...
Loss of Smell May Linger After COVID-19
WEDNESDAY, Oct. 1, 2025 -- Self-reported change or loss in smell or taste is an accurate signal of verified hyposmia after COVID-19, although there is also a high rate of hyposmia...
Elderly Patients Benefit From Screening Mammography
WEDNESDAY, Oct. 1, 2025 -- Patients with breast cancer diagnosed at 80 years of age or older who received screening mammography present with earlier-stage disease and have better...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.